NWWA
TEVA icon

New Wave Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

New Wave Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$665K Buy
19,638
+2,511
+15% +$83.6K 0.18% 113
2026
Q1 		$516K Sell
17,127
-6,917
-29% -$223K 0.18% 96
2025
Q4 		$750K Buy
24,044
+1,084
+5% +$26.7K 0.27% 71
2025
Q3 		$464K Buy
+22,960
New +$403K 0.18% 91

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

New Wave Wealth Advisors's TEVA Position: Q2 2026 in Review

New Wave Wealth Advisors increased its Teva Pharmaceuticals (TEVA) stake by 15% in Q2 2026, buying an estimated $83.6K and bringing the position to 19,638 shares worth $665K. The position accounts for 0.18% of the portfolio, ranked #113.

New Wave Wealth Advisors first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. The position peaked at $750K in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • New Wave Wealth Advisors held 19,638 shares of Teva Pharmaceuticals worth $665K as of Q2 2026.
  • New Wave Wealth Advisors bought 2,511 Teva Pharmaceuticals shares in Q2 2026, an estimated $83.6K.
  • Teva Pharmaceuticals made up 0.18% of New Wave Wealth Advisors's portfolio in Q2 2026, its #113 holding.
  • New Wave Wealth Advisors first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • New Wave Wealth Advisors's Teva Pharmaceuticals position peaked at $750K in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on New Wave Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.